Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Glycerol may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
this medicine
hs ug
Rel ie
Gotham-Black Gotham-Bold Gotham-Medium GothamCondensed-Bold GothamCondensed-Medium GothamNarrow-Black JnJBPMatrixDots-No2 PharmaBrailleUEB-Regular ZapfDingbatsITC
■
■
Tamper Evident Label Area
Rel ie
Coding (Silent Zone)
DOSE One 5 ml spoonful
Children 1 to 5 years
This product is suitable for most people, but a few people should not use it. If you are in any doubt you should contact your doctor or pharmacist.
benylin infant's cough syrup
CHILD
Black
Infant's
Magenta
Cough Syrup
Cyan
Date 09-02-2026
Glycerol
Product / Eurocode / Mat. ID Code 90065602
What the medicine looks like Benylin Infant's Cough Syrup is a colourless liquid available in 125 ml bottles. It contains 0.75 ml of the active ingredient, glycerol, in every 5 ml of medicine.
Project Name / Design GB Benylin Infants Cough Syrup 125ml/Label/CRD 15348/65249731
65249731
PC Spec
PC-0010023
Old Component / Item Code
900208D
Languages
English
Job / Version No.
404459726_r0
Infant's Cough
Date 06-02-2026
Syrup
Glycerol PANTONE 339 C
FLEXO
FLEXO
REPRESENTATION:
PANTONE 7435 C
Black
Varnish
FLEXO
FLEXO
–
3 Months +
DOSE: For oral use only
Use the larger 5 ml end of the measuring spoon provided.
Colours represented with a diagonal line have been modified to aid PDF approval.
INSTRUCTION No changes or modifications allowed to approved artwork file without written consent from local Kenvue affiliate.
Label Iniston Mucosidad and Congestion Nasal
Substrate
WHITE
Technical Code
65249731
TECHNICAL DETAILS Component
Label
Plant
McNeil Iberica
Dimensions
116 x 51 mm
Master Dieline
JJSC_00335_V3
Date 19-05-2023
Profile
Text Limit
Bleed
Fold/Technical
Perforation
Stamping Area
Coding (Silent Zone)
Print & Varnish Free
Print Free
Varnish Free
Seal Area
Tamper Evident Label Area
Braille Grid
FONTS USED Gotham-Bold Gotham-Medium GothamNarrow-Bold GothamNarrow-Medium JnJBPMatrixDots-No2
Interstate-LightCondensed
Children 3 months to 1 year:
One 5 ml spoonful. 2
MANUFACTURING SITE Reference
EXP.:
PANTONE 185 C
LOT:
CHILD
Product / Eurocode / Mat. ID Code 90065602
Children 1 to 5 years:
SMALLEST TEXT SIZE
7.00 pt AVE. TEXT SIZE
7 pt LARGEST TEXT SIZE
13.03 pt
Keep the bottle tightly closed. Do not store above 25 ̊C. Not suitable for children under Keep all medicines out of the 3 months. sight and reach of children. Give the dose 3 or 4 times within 24 hours, if Marketing Authorisation needed. holder: Please consult your pharmacist or doctor if McNeil Products Ltd, symptoms persist for more than 3 days. Reading, RG1 1LN, UK Read and retain carton for full instructions. Manufacturer: McNeil Iberica CONTENTS S.L.U Each 5 ml of syrup contains: 28805 Madrid, Spain Glycerol 0.75 ml. PL 15513/0168 Also contains: E965, E211, E1520. Two 5 ml spoonfuls.
125 ml 65249731
65249731
New Component / Item Code
This medicine is unlikely to cause side-effects unless your child is allergic to the ingredients. If your child experiences any side-effects or you are not sure about anything, talk to your doctor or pharmacist.
The active ingredient is: Glycerol 0.75 ml. Other ingredients are: Purified water, maltitol liquid (E965), citric acid, hydroxyethylcellulose, sodium citrate and sodium benzoate (E211). The flavouring is apple (containing propylene glycol (E1520).
125 ml
BRAILLE PREVIEW
If you forget to give the medicine If you forget a dose, give the next dose when needed. Do not give a double dose.
If you get any side-effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed on this carton. You can also report side-effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side-effects you can help provide more information on the safety of this medicine.
✓ Soothing relief ✓ For day & night use
Do not give to babies under 3 months.
If anyone has taken too much of this product, contact a doctor or your nearest Accident and Emergency Department (Casualty), taking this pack with you.
Reporting of side-effects
Glycerol
hs ug
y tickly s dr co ve
Talk to your doctor or pharmacist…
Benylin Infant's Cough Syrup comes as oral solution. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Benylin Infant's Cough Syrup is glycerol.
Medicines with the same active substance, strength and form include: Boots Cough Syrup 3 Months Plus, CalCough Infant Syrup, Tixylix Childrens Dry and Tickly Cough Syrup. In total there are 5 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Benylin Infant's Cough Syrup, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the relief of dry tickly coughs.
Posology
Children 3 months - 1 year: one 5ml spoonful three to four times a day.
Children 1 to 5 years: two 5ml spoonfuls three to four times a day.
Children under 3 months: not recommended.
Method of administration
For oral use.
Hypersensitivity to the active substance or to any of the ingredients listed in section 6.1.
Not recommended for children under 3 months.
Patients with rare hereditary problems of fructose intolerance should not take this medicine.
Diabetics should take note that glycerol may affect blood sugar levels.
If symptoms persist for more than 3 days or get worse, patients should stop use and consult a doctor.
This medicine contains less than 1 mmol sodium (23 mg) per 5ml, that is to say essentially 'sodium-free'.
This medicine contains 10 mg sodium benzoate (E211) in each 5ml which is equivalent to 2mg/ml.
This medicine contains 18.24 mg propylene glycol (E1520) in each 5ml which is equivalent to 3.65 mg/ml.
No clinically significant drug interactions.
Not applicable.
This medicine has no or negligible influence on the ability to drive and use machines.
Maltitol may have a mild laxative effect.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms
Overdose with this product may possibly cause diarrhoea.
Treatment
Treatment should be symptomatic and supportive.
Ask anything about Benylin Infant’s Cough Syrup. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.